Related Experiment Videos

[Chronic hepatitis C in children: natural history and prognosis]

Flavia Bortolotti1

  • 1Fondazione Lionello Forin Hepatos Onlus, Padova. flaviabortolotti@libero.it

Recenti Progressi in Medicina
|April 9, 2009
PubMed

Insights

Chronic hepatitis C in children can lead to persistent viremia and progressive liver disease into adulthood. Early treatment is recommended due to its potential benefits and the effectiveness of current therapies.

Area of Science:

  • Pediatric Hepatology
  • Viral Hepatitis Research
  • Liver Disease Progression

Context:

  • Chronic hepatitis C (HCV) is often considered mild in children.
  • However, persistent viremia is observed in over 80% of cases into adulthood.
  • Fibrosis progression and early end-stage liver disease have been documented in pediatric HCV patients.

Purpose:

  • To evaluate the long-term implications of chronic hepatitis C in children.
  • To assess the potential benefits of early therapeutic intervention in pediatric HCV cases.

Summary:

  • Contrary to previous beliefs, chronic hepatitis C in children is associated with significant long-term risks.
  • Persistent viremia, slow fibrosis progression during adolescence and youth, and early onset of end-stage liver disease are key concerns.
  • Efficacy of adult treatment strategies suggests early intervention in children may be beneficial.

Impact:

  • Highlights the need for proactive management of pediatric chronic hepatitis C.
  • Supports the consideration of early antiviral therapy in children with HCV.
  • Informs clinical guidelines for managing chronic hepatitis C in pediatric populations.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...